Oral case study/Oral presentation

Oral Presentation 3

Sat. Oct 28, 2023 9:30 AM - 10:20 AM Room 2: Subaru EAST (Hotel Nikko Tsukuba Annex Bldg.1F)

Chair: Tomomi Kamba (Kumamoto University), Taek Won Kang (Chonnam National University)

[Tomomi Kamba's Biography]
1992 Graduate from Kyoto Univ.
1992-1994 Resident, Dep. of Urol., Kyoto Univ. and Kurashiki Central Hp.
1994-1999 Staff physician, Dep. of Urol., Shiga Medical Center for Adults
1999-2003 Graduate Student, Kyoto Univ. Graduate School of Medicine
2003-2005 Postdoctoral fellow, UCSF
2005-2009 Assistant Professor, Dep. of Urol., Kyoto Univ.
2009-2014 Lecturer, Kyoto Univ.
2014-2016 Associate Professor, Dep. of Urol., Kyoto Univ.
2016-Present Professor and Chairman, Dep. of Urol., Kumamoto Univ.

[Taek Won Kang's Biography]
Kang, Taek Won

Education
1995: M.D., Chonnam National University School of Medicine, Gwangju, Korea
2004: Ph.D., Chonnam National University Postgraduate School, Gwangju, Korea

Positions
Mar. 2004 - Aug. 2006: Full-time Lecturer, Assistant Professor, Department of Urology, Chonnam National University Hospital, Gwangju, Korea
Aug. 2007 – Jun. 2009: Visiting Scholar, Lab of Urological Oncology, Department of Urology, Indiana University Purdue University Indianapolis, IN, USA
Aug. 2006 - present: Assistant Professor, Associate Professor, Professor, Department of Urology, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Korea
Mar. 2011 – Feb. 2021: Chairman, Department of Urology, Chonnam National University Hospital, Gwangju, Korea

Licensure and Certification
Licensed to Practice Medicine in Korea, 1995 (No. 56703)
Korean Board of Urology, 2003 (No. 1610)
Board of Traumatic Surgeon, 2010 (No. 2010-04)
Board of Korean Geriatric Medicine Subspecialty 2020 (No. 107)

Membership
The Korean society for urological ultrasonography, Vice president of External cooperation
The Hannam Urological Association, Director of the Planning committee
The Korean Prostate Society, Auditor
The Korean Urological Trauma and Reconstruction Society, Former President
Chonnam National University Hospital Institutional Review Board, Chairperson

+Add all to schedule

[OP3-01] Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma

*Kazuyuki Numakura¹, Yuya Sekine¹, Shingo Hatakeyama², Yumina Muto¹, Ryuta Sobu¹, Mizuki Kobayashi¹, Hajime Sasagawa¹, Soki Kashima¹, Ryohei Yamamoto¹, Taketoshi Nara^1,3, Hideo Akashi³, Ryuji Tabata⁴, Satoshi Sato⁴, Mitsuru Saito¹, Shintaro Narita¹, Chikara Ohyama², Tomonori Habuchi¹ (1. Akita University Graduate School of Medicine, 2. Hirosaki University Graduate School of Medicine, 3. Akita University Graduate School of Medicine, 4. Ageo Central General Hospital)

[OP3-02] Clinical outcome of metastatic renal cell carcinoma treated with I-O/I-O or I-O/TKI combination

*Noboru Shibasaki¹, Yuuto Hattori¹, Naoki Akagi¹, Atsushi Igarashi¹, Takanari Kambe¹, Tasuku Fujiwara¹, Akihiko Nagoshi¹, Akihiro Yamamoto¹, Mutsushi Kawakita¹, Toshinari Yamasaki¹ (1. Department of Urology, Kobe City Medical Center General Hospital)

[OP3-03] Treatment related prognostic factors in patients with retroperitoneal sarcoma: A multicenter retrospective study

*Yuki Oda¹, Makito Miyake¹, Yousuke Morizawa ¹, Shunta Hori ¹, Daisuke Gotoh¹, Yasushi Nakai¹, Kazumasa Torimoto¹, Yoshitaka Itami ², Eijiro OKajima ³, Nobumichi Tanaka ^1,4, Kiyohide Fujimoto ¹ (1. Department of Urology, Nara Medical University, Nara, Japan, 2. Department of Urology, Nara Prefecture General Medical Center, Nara, Japan, 3. Department of Urology, Nara City Hospital, Nara, Japan, 4. Prostate Brachytherapy, Nara Medical University, Nara, Japan)

[OP3-04] Cross-sectional analysis of ureteral stent occlusion in patients with malignant ureteral obstruction (MUO)

*Yuki Matsui¹, Hirotaka Kishi^1,2, Takashi Fukagai² (1. Department of Urology, Hitachi Medical Center, Ibaraki, Japan, 2. Department of Urology, Institute of Medicine, Showa University Hospital, Tokyo, Japan)

[OP3-05] The impact of Upfront combination therapy in patients with mCSPC on OS after mCRPC: a multicentre retrospective study

*Toshikazu Tanaka¹, Shingo Hatakeyama², Naoki Fujita³, Teppei Okamoto³, Hayato Yamamoto³, Takahiro Yoneyama⁴, Yasuhiro Hashimoto³, Chikara Ohyama^2,3,4 (1. Aomori prefectural central hospital, Department of Urology, 2. Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, 3. Department of Urology, Hirosaki University Graduate School of Medicine, 4. Department of Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine)

Session information